Fig. 5

CAG mitigates ECM dysfunction through NRF2 activation. (A–E) Western blot analysis and quantification of extracellular matrix proteins (COL2A1, ACAN, ADAMTS5, MMP3) in chondrocytes under NRF2 inhibition treatment (See Supplementary Materials for original blots). n = 3. (F,G) Representative images and quantitative analysis alcian blue staining of chondrocytes under si-NRF2 transfection treatment. (H,I) Representative immunofluorescence images and quantitative analysis of COL2A1. n = 3. (J,K) Representative immunofluorescence images and quantitative analysis of ADAMTS5. n = 3. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.